End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10 CNY | -2.63% | 0.00% | -36.71% |
16/05 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
25/04 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.71% | 56Cr | |
+0.85% | 9.24TCr | |
-3.03% | 3.79TCr | |
-10.46% | 3.37TCr | |
+74.71% | 2.8TCr | |
-13.39% | 1.59TCr | |
-1.08% | 1.4TCr | |
-11.15% | 1.17TCr | |
+169.04% | 1.02TCr | |
-50.19% | 1TCr |
- Stock Market
- Equities
- 688319 Stock
- News Chengdu Olymvax Biopharmaceuticals Inc.
- Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine